PYMNTS.com July 16, 2024

Artificial intelligence is making waves across the medical field, with new studies showing promise in predicting eye treatment complications, analyzing heart MRIs, and even designing RNA-based drugs.

While specialized healthcare AI models demonstrate potential, research also cautions against relying on general-purpose AI chatbots for clinical decision-making, highlighting the need for tailored solutions in critical medical applications.

AI Model Shows Promise in Predicting Eye Treatment Complications

A new study suggested AI could help predict complications from treatments for age-related macular degeneration (AMD), a leading cause of vision loss affecting millions of Americans. Researchers from Emory University and Cleveland Clinic developed a machine-learning model that analyzes eye scans to identify patients at risk of inflammatory responses to common AMD treatments.

The study,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Provider, Technology
77% of COOs Using GenAI Report Positive ROI, With Customized Tools Leading the Way
Anthropic's Claude: The AI Junior Employee Transforming Business
AI Teaches Surgery; AI Quality Registry; AI Matches Patients With Trials
Alibaba releases Qwen with Questions, an open reasoning model that beats o1-preview
Trump’s New AI Czar: Game-Changer Or A Pandora’s Box?

Share This Article